CareDx financials
$64.02−0.90%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $131.9M | $117.7M | $108.4M | $100.1M | $86.7M | $84.7M | $86.6M | $82.9M | $92.3M | $72.0M | $65.6M | $67.2M |
| Gross profit | $97.0M | $84.1M | $72.9M | $69.4M | $58.0M | $56.3M | $58.4M | $55.3M | $64.3M | $46.1M | $40.0M | $42.7M |
| Gross margin | 73.5% | 71.4% | 67.2% | 69.4% | 66.9% | 66.4% | 67.4% | 66.7% | 69.7% | 64.0% | 60.9% | 63.5% |
| Operating income | $257.0K | $1.2M | -$6.0M | -$246.0K | -$11.1M | -$13.4M | $84.4M | -$13.7M | -$7.3M | -$22.6M | -$122.6M | -$28.8M |
| Net income | $110.6M | $2.8M | -$4.1M | $1.7M | -$8.6M | -$10.4M | $87.7M | -$10.6M | -$4.6M | -$19.9M | -$118.1M | -$23.5M |
| Net margin | 83.8% | 2.4% | −3.8% | 1.7% | −9.9% | −12.2% | 101.3% | −12.8% | −5.0% | −27.6% | −180.1% | −35.0% |
| Diluted EPS | $2.07 | $0.05 | $-0.08 | $0.03 | $-0.16 | $-0.19 | $1.26 | $-0.20 | $-0.09 | $-0.38 | $-2.21 | $-0.43 |
| EBITDA | $3.1M | $5.7M | -$2.2M | $3.6M | -$7.0M | -$4.4M | -$8.6M | -$10.3M | -$3.8M | -$18.7M | -$24.9M | -$25.1M |
| Operating cash flow | $30.6M | $4.3M | $21.4M | $37.4M | $9.9M | -$26.6M | $21.9M | $12.5M | $18.9M | -$15.3M | -$8.4M | -$10.2M |
| Free cash flow | $28.7M | $514.0K | $19.4M | $36.1M | $8.9M | -$28.2M | $20.4M | $10.8M | $17.2M | -$16.8M | -$10.0M | -$11.8M |
| Diluted shares | 53.4M | 53.1M | 49.8M | 53.7M | 54.3M | 55.3M | 69.7M | 52.9M | 52.2M | 51.7M | 53.4M | 54.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $373.6M | $77.9M | $65.4M | $91.4M | $68.2M | $88.7M |
| Short-term investments | $0.00 | $109.3M | $111.8M | $102.8M | $118.0M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $533.0M | $411.1M | $413.2M | $432.3M | $444.3M | $489.6M |
| Total liabilities | $107.4M | $97.5M | $110.1M | $121.2M | $116.9M | $110.3M |
| Shareholders' equity | $425.6M | $313.5M | $303.1M | $311.1M | $327.4M | $379.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology